朊病毒病

Department of Health. Minimise transmission risk of CJD and vCJD in healthcare settings. Nov 2021 [internet publication].全文

Centers for Disease Control and Prevention. BSE (Bovine spongiform encephalopathy, or mad cow disease). Sep 2021 [internet publication].全文

American College of Radiology. ACR appropriateness criteria: movement disorders and neurodegenerative diseases. 2019 [internet publication].全文

1. Mastrianni JA, Roos RP. The prion diseases. Semin Neurol. 2000;20(3):337-52. 摘要

2. Will RG, Alperovitch A, Poser S, et al. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for CJD. Ann Neurol. 1998 Jun;43(6):763-7. 摘要

3. Prusiner SB. Shattuck lecture: neurodegenerative diseases and prions. N Engl J Med. 2001 May 17;344(20):1516-26.全文  摘要

4. Prusiner SB. The prion diseases. Brain Pathol. 1998 Jul;8(3):499-513. 摘要

5. Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13363-83.全文  摘要

6. Kong Q, Surewicz WK, Petersen RB, et al. Inherited prion diseases. In: Prusiner SB, ed. Prion biology and disease. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2004:673-776.

7. Minikel EV, Vallabh SM, Lek M, et al. Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med. 2016 Jan 20;8(322):322ra9.全文  摘要

8. Will RG. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull. 2003;66:255-265.全文  摘要

9. Brown P, Preece M, Brandel JP, et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology. 2000 Oct 24;55(8):1075-81. 摘要

10. Peden A, McCardle L, Head MW, et al. Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia. 2010 Mar;16(2):296-304. 摘要

11. Will RG, Zeidler M, Stewart GE, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol. 2000 May;47(5):575-82. 摘要

12. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996 Apr 6;347(9006):921-5. 摘要

13. Heath CA, Cooper SA, Murray K, et al. Diagnosing variant Creutzfeldt-Jakob disease: a retrospective analysis of the first 150 cases in the UK. J Neurol Neurosurg Psychiatry. 2011 Jun;82(6):646-51. 摘要

14. Collins SJ, Sanchez-Juan P, Masters CL, et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain. 2006 Sep;129(Pt 9):2278-87.全文  摘要

15. Panagariya A, Jain RS, Sharma AK. Stroke like presentation of Creutzfeldt Jakob disease: an unusual variant. J Assoc Physicians India. 1999 May;47(5):548-50. 摘要

16. Jacobs DA, Lesser RL, Mourelatos Z, et al. The Heidenhain variant of Creutzfeldt-Jakob disease: clinical, pathologic, and neuroimaging findings. J Neuroophthalmol. 2001 Jun;21(2):99-102. 摘要

17. Kropp S, Schulz-Schaeffer WJ, Finkenstaedt M, et al. The Heidenhain variant of Creutzfeldt-Jakob disease. Arch Neurol. 1999 Jan;56(1):55-61.全文  摘要

18. Poon MA, Stuckey S, Storey E. MRI evidence of cerebellar and hippocampal involvement in Creutzfeldt- Jakob disease. Neuroradiology. 2001 Sep;43(9):746-9. 摘要

19. Belay ED, Holman RC, Schonberger LB. Creutzfeldt-Jakob disease surveillance and diagnosis. Clin Infect Dis. 2005 Sep 15;41(6):834-6. 摘要

20. Laske C, Gefeller O, Pfahlberg A, et al. The effect of stress on the onset and progression of Creutzfeldt-Jakob disease: results of a German pilot case-control study. Eur J Epidemiol. 1999 Aug;15(7):631-5. 摘要

21. Will R. Variant Creutzfeldt-Jakob disease. Folia Neuropathol. 2004;42(suppl A):77-83. 摘要

22. Kovács GG, Puopolo M, Ladogana A, et al. Genetic prion disease: the EUROCJD experience. Hum Genet. 2005 Nov;118(2):166-74. 摘要

23. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999 Aug;46(2):224-33. 摘要

24. Hamaguchi T, Noguchi-Shinohara M, Nozaki I, et al. The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures. Neuropathology. 2009 Oct;29(5):625-31. 摘要

25. Peretz D, Supattapone S, Giles K, et al. Inactivation of prions by acidic sodium dodecyl sulfate. J Virol. 2006 Jan;80(1):322-31.全文  摘要

26. Douet JY, Lacroux C, Aron N, et al. Distribution and quantitative estimates of variant Creutzfeldt-Jakob Disease prions in tissues of clinical and asymptomatic patients. Emerg Infect Dis. 2017 Jun;23(6):946-956.全文  摘要

27. Department of Health. Minimise transmission risk of CJD and vCJD in healthcare settings. Nov 2021 [internet publication].全文

28. Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature. 1997 Oct 2;389(6650):498-501. 摘要

29. Peden AH, Head MW, Ritchie DL, et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet. 2004 Aug 7-13;364(9433):527-9. 摘要

30. Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet. 2004 Feb 7;363(9407):417-21. 摘要

31. Wroe SJ, Pal S, Siddique D, et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet. 2006 Dec 9;368(9552):2061-7. 摘要

32. Dorsey K, Zou S, Schonberger LB, et al. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study. Transfusion. 2009 May;49(5):977-84. 摘要

33. Zou S, Fang CT, Schonberger LB. Transfusion transmission of human prion diseases. Transfus Med Rev. 2008 Jan;22(1):58-69. 摘要

34. Goold R, Rabbanian S, Sutton L, et al. Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat Commun. 2011;2:281.全文  摘要

35. Norrby E. Prions and protein-folding diseases. J Intern Med. 2011 Jul;270(1):1-14. 摘要

36. Kretzschmar HA, Ironside JW, DeArmond SJ, et al. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol. 1996 Sep;53(9):913-20. 摘要

37. Hill AF, Butterworth RJ, Joiner S, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet. 1999 Jan 16;353(9148):183-9. 摘要

38. DeArmond SJ, Prusiner SB. Perspectives on prion biology, prion disease pathogenesis, and pharmacologic approaches to treatment. Clin Lab Med. 2003 Mar;23(1):1-41. 摘要

39. Freixes M, Rodriguez A, Dalfo E, et al. Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob disease. Neurobiol Aging. 2006 Dec;27(12):1807-15. 摘要

40. Bleich S, Kropp S, Degner D, et al. Creutzfeldt-Jakob disease and oxidative stress. Acta Neurol Scand. 2000 May;101(5):332-4. 摘要

41. Minghetti L, Pocchiari M. Cyclooxygenase-2, prostaglandin E2, and microglial activation in prion diseases. Int Rev Neurobiol. 2007;82:265-75. 摘要

42. Bouzamondo-Bernstein E, Hopkins SD, Spilman P, et al. The neurodegeneration sequence in prion diseases: evidence from functional, morphological and ultrastructural studies of the GABAergic system. J Neuropathol Exp Neurol. 2004 Aug;63(8):882-99. 摘要

43. DeArmond SJ, Sanchez H, Yehiely F, et al. Selective neuronal targeting in prion disease. Neuron. 1997 Dec;19(6):1337-48. 摘要

44. Prusiner SB, Groth D, Serban A, et al. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10608-12.全文  摘要

45. Bueler H, Aguzzi A, Sailer A, et al. Mice devoid of PrP are resistant to scrapie. Cell. 1993 Jul 2;73(7):1339-47. 摘要

46. Sailer A, Bueler H, Fischer M, et al. No propagation of prions in mice devoid of PrP. Cell. 1994 Jul 1;77(7):967-8. 摘要

47. Legname G, Baskakov IV, Nguyen HO, et al. Synthetic mammalian prions. Science. 2004 Jul 30;305(5684):673-6. 摘要

48. Makarava N, Kovacs GG, Bocharova O, et al. Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol. 2010 Feb;119(2):177-87. 摘要

49. Prusiner SB. Detecting mad cow disease. Sci Am. 2004 Jul;291(1):86-93. 摘要

50. Brandel JP, Vlaicu MB, Culeux A, et al. Variant Creutzfeldt-Jakob Disease Diagnosed 7.5 Years after Occupational Exposure. N Engl J Med. 2020 Jul 2;383(1):83-85.全文  摘要

51. UK Health Protection Agency. Variant CJD and plasma products. January 2007. [internet publication].全文

52. Puopolo M, Ladogana A, Vetrugno V, et al. Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases. Transfusion. 2011 Jul;51(7):1556-66. 摘要

53. Creutzfeldt-Jakob Disease International Surveillance Network. CJD surveillance data 1993-2013. [internet publication].全文

54. Centers for Disease Control and Prevention. BSE (Bovine spongiform encephalopathy, or mad cow disease). Sep 2021 [internet publication].全文

55. World Organisation for Animal Health. Number of reported cases of bovine spongiform encephalopathy (BSE) in farmed cattle worldwide* (excluding the United Kingdom). 2017. [internet publication].全文

56. Scott MR, Will R, Ironside J, et al. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci US. 1999 Dec 21;96(26):15137-42.全文  摘要

57. Williams ES. Chronic wasting disease. Vet Pathol. 2005 Sep;42(5):530-49. 摘要

58. Waddell L, Greig J, Mascarenhas M, et al. Current evidence on the transmissibility of chronic wasting disease prions to humans: a systematic review. Transbound Emerg Dis. 2017 [Epub ahead of print].全文  摘要

59. Miller MW, Williams ES. Chronic wasting disease of cervids. Curr Top Microbiol Immunol. 2004;284:193-214. 摘要

60. Angers RC, Browning SR, Seward TS, et al. Prions in skeletal muscles of deer with chronic wasting disease. Science. 2006 Feb 24;311(5764):1117. 摘要

61. Mawhinney S, Pape WJ, Forster JE, et al. Human prion disease and relative risk associated with chronic wasting disease. Emerg Infect Dis. 2006 Oct;12(10):1527-35. 摘要

62. Lewis AM, Yu M, DeArmond SJ, et al. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease with abnormal imaging. Arch Neurol. 2006 Feb;63(2):288-90.全文  摘要

63. National Institute for Health and Care Excellence. Reducing the risk of transmission of Creutzfeldt–Jakob disease (CJD) from surgical instruments used for interventional procedures on high-risk tissues. Jan 2020 [internet publication].全文

64. National Institute for Health and Care Excellence. Donor breast milk banks: the operation of donor milk bank services. February 2010. [internet publication].全文

65. Young GS, Geschwind MD, Fischbein NJ, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol. 2005 Jun-Jul;26(6):1551-62.全文  摘要

66. Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009 Oct;132(Pt 10):2659-68.全文  摘要

67. Vitali P, Maccagnano E, Caverzasi E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011 May 17;76(20):1711-9. 摘要

68. Groveman BR, Orrú CD1, Hughson AG, et al. Extended and direct evaluation of RT-QuIC assays for Creutzfeldt-Jakob disease diagnosis. Ann Clin Transl Neurol. 2016 Dec 27;4(2):139-144.全文  摘要

69. Hermann P, Appleby B, Brandel JP, et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 2021 Mar;20(3):235-246.全文  摘要

70. Centers for Disease Control and Prevention. CDC’s Diagnostic Criteria for Creutzfeldt-Jakob Disease (CJD). 2018 [internet publication]全文

71. Geschwind MD, Jay C. Assessment of rapidly progressive dementias. Concise review related to chapter 362: Alzheimer disease and other primary dementias. In: Braunwald E, Harrison TR, Fauci AS, et al, eds. Harrison's principles of internal medicine. New York, NY: McGraw-Hill; 2001:2391-2398.

72. Rabinovici GD, Wang PN, Levin J, et al. First symptom in sporadic Creutzfeldt-Jakob disease. Neurology. 2006 Jan 24;66(2):286-7. 摘要

73. Prusiner SB, Bosque PJ. Prion diseases. In: Braunwald E, Harrison TR, Fauci AS, et al, eds. Harrison's principles of internal medicine. New York, NY: McGraw-Hill; 2001:2486-2491.

74. Collins S, McLean CA, Masters CL. Gerstmann-Sträussler-Scheinker syndrome,fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies. J Clin Neurosci. 2001 Sep;8(5):387-97. 摘要

75. Gambetti P, Kong Q, Zou W, et al. Sporadic and familial CJD: classification and characterisation. Br Med Bull. 2003;66:213-39. 摘要

76. American College of Radiology. ACR appropriateness criteria: movement disorders and neurodegenerative diseases. 2019 [internet publication].全文

77. Shiga Y, Miyazawa K, Sato S, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology. 2004 Aug 10;63(3):443-9. 摘要

78. Finkenstaedt M, Szudra A, Zerr I, et al. MR imaging of Creutzfeldt-Jakob disease. Radiology. 1996 Jun;199(3):793-8. 摘要

79. Collie DA, Sellar RJ, Zeidler M, et al. MRI of Creuztfeldt-Jakob disease: imaging features and recommended MRI protocol. Clin Radiol. 2001 Sep;56(9):726-39. 摘要

80. Keohane C. Pulvinar sign on MRI images in variant Creutzfeldt-Jakob disease. Lancet. 2000 Apr 22;355(9213):1384. 摘要

81. Zeidler M, Sellar RJ, Collie DA, et al. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt- Jakob disease. Lancet. 2000 Apr 22;355(9213):1412-8. 摘要

82. Steinhoff BJ, Zerr I, Glatting M, et al. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol. 2004 Nov;56(5):702-8. 摘要

83. Chitravas N, Jung RS, Kofskey DM, et al. Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol. 2011 Sep;70(3):437-44.全文  摘要

84. Muayqil T, Gronseth G, Camicioli R. Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2012 Oct 2;79(14):1499-506.全文  摘要

85. Tschampa HJ, Neumann M, Zerr I, et al. Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 2001 Jul;71(1):33-9.全文  摘要

86. Geschwind M, Haman A, Torres-Chae C, et al. CSF findings in a large United States sporadic CJD cohort. Neurology. 2007;68(suppl 1):A142.

87. Huntington's Disease Society of America. Genetic testing for Huntington’s disease: its relevance and implications. 2003. [internet publication].全文

88. de Priester JA, Jansen GH, de Kruijk JR, et al. New MRI findings in Creutzfeldt-Jakob disease: high signal in the globus pallidus on T1-weighted images. Neuroradiology. 1999 Apr;41(4):265-8. 摘要

89. Satoh J, Kurohara K, Yukitake M, et al. The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture. Eur Neurol. 1999;41(4):216-25. 摘要

90. Satoh K, Shirabe S, Eguchi H, et al. 14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan. Cell Mol Neurobiol. 2006 Feb;26(1):45-52. 摘要

91. Chapman T, McKeel DW Jr, Morris JC. Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2000 Nov 14;55(9):1396-7. 摘要

92. Sanchez-Juan P, Green A, Ladogana A, et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology. 2006 Aug 22;67(4):637-43. 摘要

93. Moussavian M, Potolicchio S, Jones R. The 14-3-3 brain protein and transmissible spongiform encephalopathy. N Engl J Med. 1997 Mar 20;336(12):873-4 摘要

94. Hsich G, Kenney K, Gibbs CJ, et al. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med. 1996 Sep 26;335(13):924-30.全文  摘要

95. Tschampa HJ, Kallenberg K, Urbach H, et al. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. Brain. 2005 Sep;128(Pt 9):2026-33.全文  摘要

96. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939-44. 摘要

97. Rabinovici GD, Furst AJ, O'Neil JP, et al. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology. 2007 Apr 10;68(15):1205-12. 摘要

98. Haik S, Brandel JP, Sazdovitch V, et al. Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt-Jakob disease. Neurology. 2000 Nov 14;55(9):1401-4. 摘要

99. McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis. 2006;9(suppl):417-423. 摘要

100. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005 Dec 27;65(12):1863-72. 摘要

101. Catani M, Piccirilli M, Geloso MC, et al. Rapidly progressive aphasic dementia with motor neuron disease: a distinctive clinical entity. Dement Geriatr Cogn Disord. 2004;17(1-2):21-8. 摘要

102. Mackenzie IR, Feldman H. Neurofilament inclusion body disease with early onset frontotemporal dementia and primary lateral sclerosis. Clin Neuropathol. 2004 Jul-Aug;23(4):183-93. 摘要

103. Roberson ED, Hesse JH, Rose KD, et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology. 2005 Sep 13;65(5):719-25. 摘要

104. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998 Dec;51(6):1546-54. 摘要

105. Avanzino L, Marinelli L, Buccolieri A, et al. Creutzfeldt-Jakob disease presenting as corticobasal degeneration: a neurophysiological study. Neurol Sci. 2006 Jun;27(2):118-21. 摘要

106. Ferro JM. Vasculitis of the central nervous system. J Neurol. 1998 Dec;245(12):766-76. 摘要

107. Moore PM, Richardson B. Neurology of the vasculitides and connective tissue diseases. J Neurol Neurosurg Psychiatry. 1998 Jul;65(1):10-22.全文  摘要

108. Younger DS, Kass RM. Vasculitis and the nervous system. Historical perspective and overview. Neurol Clin. 1997 Nov;15(4):737-58. 摘要

109. Josephson SA, Papanastassiou AM, Berger MS, et al. The diagnostic utility of brain biopsy procedures in patients with rapidly deteriorating neurological conditions or dementia. J Neurosurg. 2007 Jan;106(1):72-5.全文  摘要

110. Vernino S, Geschwind MD, Boeve B. Autoimmune encephalopathies. Neurologist. 2007 May;13(3):140-7. 摘要

111. Dropcho EJ. Paraneoplastic diseases of the nervous system. Curr Treat Options Neurol. 1999 Nov;1(5):417-427. 摘要

112. Gultekin SH, Rosenfeld MR, Voltz R, et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000 Jul;123 ( Pt 7):1481-94.全文  摘要

113. Tuzun E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist. 2007 Sep;13(5):261-71. 摘要

114. Rosenbloom MH, Smith S, Akdal G, et al. Immunologically mediated dementias. Curr Neurol Neurosci Rep. 2009 Sep;9(5):359-67.全文  摘要

115. Kothbauer-Margreiter I, Sturzenegger M, Komor J, et al. Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J Neurol. 1996 Aug;243(8):585-93. 摘要

116. Seipelt M, Zerr I, Nau R, et al. Hashimoto's encephalitis as a differential diagnosis of Creutzfeldt- Jakob disease. J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):172-6.全文  摘要

117. Josephs KA, Rubino FA, Dickson DW. Nonvasculitic autoimmune inflammatory meningoencephalitis. Neuropathology. 2004 Jun;24(2):149-52. 摘要

118. Castillo P, Woodruff B, Caselli R, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006 Feb;63(2):197-202.全文  摘要

119. Chong JY, Rowland LP. What's in a NAIM? Hashimoto encephalopathy, steroid-responsive encephalopathy associated with autoimmune thyroiditis, or nonvasculitic autoimmune meningoencephalitis? Arch Neurol. 2006 Feb;63(2):175-6. 摘要

120. Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth? Arch Neurol. 2003 Feb;60(2):164-71.全文  摘要

121. Geschwind MD, Yoon G, Goldman J. Adult-onset genetic disorders involving the frontal lobes. In: Miller BL, Cummings JF, eds. The human frontal lobes: functions and disorders. 2nd ed. New York: Guilford Press; 2007:552-575.

122. Geschwind MD, Haman A, Miller BL. Rapidly progressive dementia. Neurol Clin. 2007 Aug;25(3):783-807, vii. 摘要

123. Cavalier L, Ouahchi K, Kayden HJ, et al. Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families. Am J Hum Genet. 1998 Feb;62(2):301-10.全文  摘要

124. Kitzberger R, Madl C, Ferenci P. Wilson disease. Metab Brain Dis. 2005 Dec;20(4):295-302. 摘要

125. Ross ME, Jacobson IM, Dienstag JL, et al. Late-onset Wilson's disease with neurological involvement in the absence of Kayser-Fleischer rings. Ann Neurol. 1985 Apr;17(4):411-3. 摘要

126. Molina JA, Jimenez-Jimenez FJ, Calandre L. Bismuth encephalopathy. Neurology. 1994 Mar;44(3 Pt 1):582. 摘要

127. Teepker M, Hamer HM, Knake S, et al. Myoclonic encephalopathy caused by chronic bismuth abuse. Epileptic Disord. 2002 Dec;4(4):229-33. 摘要

128. Jungreis AC, Schaumburg HH. Encephalopathy from abuse of bismuth subsalicylate (Pepto-Bismol). Neurology. 1993 Jun;43(6):1265. 摘要

129. Le Quesne PM. Metal-induced diseases of the nervous system. Br J Hosp Med. 1982 Nov;28(5):534-8. 摘要

130. Timmermans M, Carr J. Neurosyphilis in the modern era. J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1727-30.全文  摘要

131. Fallon BA, Nields JA, Parsons B, et al. Psychiatric manifestations of Lyme borreliosis. J Clin Psychiatry. 1993 Jul;54(7):263-8. 摘要

132. Kaplan RF, Jones-Woodward L. Lyme encephalopathy: a neuropsychological perspective. Semin Neurol. 1997 Mar;17(1):31-7. 摘要

133. Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008 Mar 25;70(13):992-1003. 摘要

134. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990 Nov 22;323(21):1438-44. 摘要

135. Louis ED, Lynch T, Kaufmann P, et al. Diagnostic guidelines in central nervous system Whipple's disease. Ann Neurol. 1996 Oct;40(4):561-8. 摘要

136. Ghezzi A, Zaffaroni M. Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis. Neurol Sci. 2001 Nov;22 Suppl 2:S117-22. 摘要

137. Durand DV, Lecomte C, Cathebras P, et al. Whipple disease: clinical review of 52 cases. The SNFMI Research Group on Whipple Disease. Societe Nationale Francaise de Medecine Interne. Medicine (Baltimore). 1997 May;76(3):170-84. 摘要

138. Zoonotic Disease Division of Emerging and other Communicable Diseases Surveillance and Control. Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation. Geneva, Switzerland: WHO; 1998.全文

139. Shaked GM, Engelstein R, Avraham I, et al. Valproic acid treatment results in increased accumulation of prion proteins. Ann Neurol. 2002 Oct;52(4):416-20. 摘要

140. Sander JW, Duncan JS. Valproic acid and prion proteins. Ann Neurol. 2003 May;53(5):688-9. 摘要

141. US Food and Drug Administration. Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist)​. 2018 [internet publication]全文

142. Spencer MD, Knight RS, Will RG. First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features. BMJ. 2002 Jun 22;324(7352):1479-82.全文  摘要

143. Gill ON, Spencer Y, Richard-Loendt A, et al. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ. 2013 Oct 15;347:f5675.全文  摘要